We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Somaxon Hits Par With IP Suit Over Silenor Generic

Law360 (February 2, 2011, 8:03 PM EST) -- Somaxon Pharmaceuticals Inc. slapped Par Pharmaceutical Cos. Inc. with a patent infringement suit Wednesday over Par's bid for regulatory approval to market generic versions of Somaxon's insomnia drug Silenor.

Somaxon and...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.